After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA
In Brief: Comis Named ECOG Chairman; Long Joins Capitol Associates; Chabner Day In Shelbyville
Advisors’ Report On Intramural Program To Recommend Restructuring
Russian-American Breast Cancer Meeting Canceled
Breast Cancer Plan Issues Its First RFA, Other Initiatives To Be Announced Soon
NCI, EORTC Offer Support For Russian Cancer Researchers
Public Forum On NRSA Tuition Policies
Trending Stories
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
- Most Favored Nation drug pricing could put China on top
- NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown
- Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line









